articleThe LancetNov 19, 2020BRONZE OA

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

MNMaheshi N RamasamyAMAngela M MinassianKJKatie J EwerALAmy L FlaxmanPMPedro M Folegatti

Jenner Institute · University of Oxford · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,404
total citations
FWCI
31.76
Percentile
100%
References
24
Citations per year

Authors

421
  • MN
    Maheshi N RamasamyCorresponding
  • AM
    Angela M Minassian

    Jenner Institute, University of Oxford

  • KJ
    Katie J Ewer

    University of Oxford, Jenner Institute

  • AL
    Amy L Flaxman

    Jenner Institute, University of Oxford

  • PM
    Pedro M Folegatti

    Jenner Institute, University of Oxford

Topics & keywords

Keywords
  • Immunogenicity
  • Regimen
  • Clinical trial
  • Preparedness
  • Vaccination
  • Clinical research
  • MEDLINE
  • Public health
No related works found for this paper.

Funding